Evaluation of the Validity of Preemptive Therapy against Cytomegalovirus Disease Based on Antigenemia Assay with a Cutoff of 20 Positive Cells per Two Slides-Reference-Cited by-同舟云学术

Evaluation of the Validity of Preemptive Therapy against Cytomegalovirus Disease Based on Antigenemia Assay with a Cutoff of 20 Positive Cells per Two Slides

Published:2013-09-05 Issue:9 Volume:8 Page:e73754
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sakamoto Kana,Nakasone Hideki,Wada Hidenori,Yamasaki Ryoko,Ishihara Yuko,Kawamura Koji,Ashizawa Masahiro,Sato Miki,Terasako-Saito Kiriko,Machishima Tomohito,Kimura Shun-Ichi,Kikuchi Misato,Kako Shinichi,Kanda Junya,Yamazaki Rie,Tanihara Aki,Nishida Junji,Kanda Yoshinobu

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan;Y Kanda;Bone Marrow Transplant,2001

2. Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation;Y Kanda;Transplantation,2002

3. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation;T Mori;Bone Marrow Transplant,2004

4. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study;M Boeckh;Blood,1996

5. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation;H Einsele;Blood,1995

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a nomogram to predict the risk of secondary failure of platelet recovery in patients with β-thalassemia major after hematopoietic stem cell transplantation: a retrospective study;Therapeutic Advances in Hematology;2024-01

2. Case report: Irinotecan-induced interstitial lung disease in an advanced colorectal cancer patient resurfacing decades after allogeneic bone marrow transplantation for aplastic anemia; a case report and narrative review of literature;Frontiers in Oncology;2023-06-16

3. Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation;Communications Biology;2021-10-11

4. Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non‐relapse mortality after allogeneic hematopoietic stem cell transplantation;Transplant Infectious Disease;2021-08-26

5. Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2021-08